Clinical trials
Observational Genetic Diseases, Inborn trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 10 |
| Unknown status | 6 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut National de la Santé Et de la Recherche Médicale, France | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Hospices Civils de Lyon | 2 |
| Imagine Institute | 2 |
| Nantes University Hospital | 2 |
| Novo Nordisk A/S | 2 |
| QED Therapeutics, a BridgeBio company | 2 |
| Swedish Orphan Biovitrum | 2 |
| University Hospital, Montpellier | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genetic Diseases, Inborn | 32 |
| Nervous System Diseases | 6 |
| Autoimmune Diseases | 3 |
| Blood Coagulation Disorders | 3 |
| Coagulation Protein Disorders | 3 |
| Hematologic Diseases | 3 |
| Hemophilia A | 3 |
| Hemorrhagic Disorders | 3 |
| Rare Diseases | 3 |
| Bone Diseases | 2 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.